Researchers and biotech companies alike have been investigating the use of nanoparticles as carriers of drugs (small molecules and biologics). The advantage of using nanocarriers lies in their ability to overcome various biological barriers and to localize into the target tissue when administered systemically.
The unique physical characteristics of NanoDendrixTM combined with its safety profile make it an ideal nanocarrier for drugs. Glysantis R&D activities are currently investigating the use of NanoDendrixTM as a nanocarrier for the following drug delivery applications:
- Delivery of nucleic acid based drugs.
- Transdermal, needle-free drug delivery.
- Intranasal delivery of active pharmaceutical ingredients (APIs).
- Reduce unwanted toxicity of drugs and chemotherapeutic agents, effectively increasing the therapeutic window and potential efficacy.